Advisor Group Holdings, Inc. Forward Pharma A/S Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$4.24 - $6.03 $4,240 - $6,030	-1,000 Reduced 99.9%	1 $0
Q1 2022 May 04, 2022	BUY	$5.06 - $6.15 $5,060 - $6,150	1,000 Added 100000.0%	1,001 $6,000
Q1 2021 May 13, 2021	SELL	$6.51 - $9.0 $9,765 - $13,500	-1,500 Reduced 99.93%	1 $0
Q4 2020 Feb 10, 2021	BUY	$6.22 - $7.4 $9,330 - $11,100	1,500 Added 150000.0%	1,501 $11,000
Q3 2020 Nov 12, 2020	SELL	$5.99 - $6.78 $8,985 - $10,170	-1,500 Reduced 99.93%	1 $0
Q2 2020 Aug 14, 2020	BUY	$5.16 - $7.77 $7,740 - $11,655	1,500 Added 150000.0%	1,501 $9,000
Q1 2020 May 18, 2020	BUY	$4.92 - $7.7 $4 - $7	1 New	1 $0

Ticker FWP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,091,180
Market Cap $18.2M
Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.